AASLD 2021: The FXR Agonist TERN-101 Shows Promise Against NASH Phase 2a
The drug reduced key parameters of NASH.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
The drug reduced key parameters of NASH.
Only registered members have full access to PracticeUpdate content.